NHS Breast Screening Programme: Ages and Process

Overview

Breast screening is one of three national cancer screening programmes in England. The NHS Breast Screening Programme invites women aged fifty to seventy-one for a mammogram every three years; women over seventy-one can request continued screening through self-referral. The programme detects breast cancer at an earlier stage, when treatment is more likely to be successful. As with all screening, there are benefits (early detection, fewer cancer deaths) and risks (false positives, overdiagnosis); the patient information leaflet explains both.

Who gets invited

Women registered with a GP in England are invited from age fifty in three-yearly cycles. The first invitation typically arrives between fiftieth and fifty-third birthdays. The last routine invitation is at age seventy-one. Trans men, non-binary and trans women may be invited or able to self-refer depending on their NHS-recorded gender and individual circumstances. The screening centres can advise on the appropriate pathway.

The mammogram appointment

The mammogram is done at a screening centre, mobile unit or hospital department. Each breast is positioned on the X-ray plate and gently compressed for a few seconds while the image is taken. Two views per breast are standard. The appointment takes around thirty minutes including check-in and information. Some women find the compression uncomfortable; the procedure itself is brief.

Results and follow-up

Results are sent by post within two weeks. The vast majority of results are 'no signs of cancer', with the next invitation due in three years. A small proportion are recalled for further assessment, which can involve more detailed mammograms, ultrasound, examination by a doctor and (where indicated) needle biopsy. Most recall assessments do not find cancer; the proportion that do varies by age and other factors.

Benefits, risks and informed choice

Screening reduces breast cancer mortality by detecting cancers earlier when treatment is more effective. Against this, screening carries risks: false positives (recall and worry without cancer), overdiagnosis (detection of cancers that would never have caused harm in the woman's lifetime, resulting in treatment of cancers that did not need it), and the small radiation dose. The NHS information leaflet explains the figures; the choice to attend is individual.

Devolved nation variations: Scotland, Wales, Northern Ireland

NHS arrangements vary across the four UK nations under their respective health and social care frameworks. NHS Scotland operates under the Scottish Government and offers free prescriptions, free dental examinations and somewhat different commissioning arrangements through Health Boards rather than Integrated Care Boards. NHS Wales is the equivalent body in Wales with free prescriptions and integrated public health functions through Public Health Wales.

Health and Social Care Northern Ireland (HSC) is the integrated health and social care provider in Northern Ireland, structured differently from NHS England with combined health and social work commissioning. Prescription charges are free in all three devolved nations. Cross-border patients may move between systems; reciprocal arrangements within the UK mean treatment is generally accessible regardless of which nation issued the patient's NHS number.

Specific service availability, waiting times and commissioning priorities differ between the nations. Patient information is published by NHS Inform (Scotland), NHS 111 Wales and HSC Northern Ireland respectively. Cross-border referrals use established protocols between trusts and Health Boards.

Complaints, advocacy and patient voice

NHS complaints follow the NHS Complaints Regulations 2009. The first step is the provider's own complaints process (most trusts have a complaints team and a Patient Advice and Liaison Service for informal resolution). The trust must acknowledge complaints within three working days and respond substantively within a reasonable period, normally six months.

Unresolved complaints can be escalated to the Parliamentary and Health Service Ombudsman (PHSO), which investigates maladministration in NHS services. Independent advocacy is available free through the Independent NHS Complaints Advocacy Service commissioned by each local authority. Specialist advocacy on clinical negligence is provided by Action Against Medical Accidents (AvMA).

Healthwatch operates at local and national level as the statutory patient voice, gathering feedback and influencing commissioning decisions. The Care Quality Commission (CQC) inspects and rates NHS services from 'Inadequate' to 'Outstanding'; reports are published at cqc.org.uk and offer patient-facing information on service quality. Integrated Care Boards in England commission most NHS services and have public-facing complaints and feedback channels.

Confirming your NHS entitlement on arrival

Most UK residents are entitled to NHS care free at the point of use. The Department of Health and Social Care publishes guidance setting out who is exempt from charges and who is chargeable. Visa holders pay the Immigration Health Surcharge upfront with their visa application and are then entitled to the same NHS access as settled residents for the duration of the visa.

Patients can confirm their NHS number through the NHS App or by phoning the local GP surgery once registered. The NHS number is the identifier across all NHS services including hospitals, dentists, pharmacies and screening programmes. Without an NHS number, services can still treat the patient but record-keeping is harder.

Special groups have specific entitlement protections: asylum seekers and refugees are exempt from hospital charges under the Charges to Overseas Visitors Regulations 2015; victims of modern slavery, looked-after children and certain other groups have specific exemptions. The NHS website nhs.uk/using-the-nhs/about-the-nhs/healthcare-in-england-for-visitors-from-overseas/ sets out the categories.

How NHS services are commissioned and funded

NHS services in England are commissioned by Integrated Care Boards (ICBs), forty-two regional bodies established in 2022 under the Health and Care Act 2022. Each ICB plans, commissions and pays for NHS services for its population, replacing the previous Clinical Commissioning Groups. Commissioning includes primary care (through the NHS England regional teams in some areas), secondary care from NHS Trusts, community services, mental health services, and continuing healthcare.

Funding flows from the Department of Health and Social Care to NHS England, which allocates to ICBs based on a formula reflecting population size, age structure, deprivation and other factors. ICBs then contract with providers for specific services. The provider mix includes NHS Trusts (the majority of secondary care), GP practices (contracts under the General Medical Services or alternative contracts), independent providers under NHS Standard Contract, and charity-sector providers for some specialised services.

Patient choice operates within the commissioning framework: patients can choose between providers for non-urgent consultant-led care via the e-Referral Service. Specialist services are commissioned at regional or national level for very rare or technically demanding care. Local Authority commissioning covers adult social care, public health functions (smoking cessation, sexual health) and certain children's services.

Quality, safety and patient feedback channels

The Care Quality Commission (CQC) is the independent regulator of all NHS and many independent health and social care services in England. CQC inspections rate services from 'Inadequate' to 'Outstanding' based on five key questions: Are they safe, effective, caring, responsive and well-led? Reports are published at cqc.org.uk and patients can use them when choosing providers.

The National Institute for Health and Care Excellence (NICE) issues guidance on clinical practice, technology appraisals (which drugs and devices the NHS should fund) and quality standards. NICE Technology Appraisal Guidance is mandatory for NHS commissioning in England within ninety days of publication. NICE Clinical Guidelines are advisory but widely followed.

Patient feedback is gathered through the Friends and Family Test (a single-question score at point of care), patient surveys including the National GP Patient Survey published by NHS England, NHS choices/nhs.uk patient reviews, and Healthwatch local and national bodies. Patient feedback informs commissioning decisions, CQC inspection priorities and ongoing improvement at provider level.

Your rights as an NHS patient

The NHS Constitution sets out patient rights under the NHS in England. Key rights include: the right to NHS services free at the point of use except where charges are authorised; the right to access NHS services within maximum waiting times; the right to choice of provider; the right to be involved in decisions about your care; the right to be treated with dignity and respect; the right to confidentiality; the right to access your own health records; the right to complain and have complaints investigated.

Specific waiting-time rights include the eighteen-week right to start consultant-led treatment after referral, the two-week wait for suspected cancer referrals and the four-hour A&E target. These rights are not absolute (the NHS Constitution states they apply 'where clinically appropriate') but are enforceable through complaints and ultimately judicial review in extreme cases. The trust must offer an alternative provider where it cannot meet the eighteen-week target.

Choice rights cover most planned consultant-led care. Patients can choose between providers at the point of GP referral through the NHS e-Referral Service. Choice does not apply to emergency care, mental health detention, or some specialised tertiary services. Patient choice protections are an important lever for those facing long local waits; alternative providers in nearby regions can be accessed under the same NHS terms.

Confidentiality and data rights are governed by the UK GDPR, the Data Protection Act 2018 and NHS-specific guidance. Patients can access their own records through the NHS App or by Subject Access Request. Data sharing for direct care is permitted; secondary uses (research, planning) require either consent or compatibility with the National Data Opt-Out. Specific data flows including the Summary Care Record and Shared Care Record have additional governance.

Provider types: NHS Trusts, Foundation Trusts, private under NHS contract

NHS Trusts deliver hospital and community services. Foundation Trusts have additional autonomy from central government but operate under the same NHS rules. Both are regulated by the Care Quality Commission and NHS England. Each Trust has a chief executive, a board of directors, governors and a clinical leadership team.

Independent (private) sector providers deliver some NHS services under NHS Standard Contract. The arrangement provides NHS-funded care from a private hospital, often for elective surgery to reduce NHS waiting times. The patient experience is NHS-style (NHS funding, NHS waiting-time entitlement) delivered in a private hospital setting. Major independent providers serving NHS patients include Spire, Nuffield Health, Ramsay, Circle and BMI Healthcare in some areas.

Primary care is delivered by GP practices contracted under the General Medical Services contract or Personal Medical Services arrangement. Practices are independent businesses contracted with the NHS, not NHS-owned. Many practices have multiple sites and operate at scale; others are single-site small partnerships. Primary Care Networks (groups of practices serving 30,000 to 50,000 patients) coordinate care across practices and host shared roles including First Contact Physiotherapists and clinical pharmacists.

Community services (district nursing, community physiotherapy, mental health teams, learning disability teams) are commissioned by ICBs and provided by NHS Trusts, social enterprises or charity-sector providers depending on the area. Mental health trusts handle specialist mental health services including inpatient psychiatric care, community mental health teams and specialist services. Ambulance services are provided by ten regional NHS ambulance trusts in England.

NHS technology and digital transformation

NHS digital transformation has accelerated since 2020. The NHS App now covers most major patient touchpoints: appointment booking, prescription ordering, medical record access, NHS 111 online integration. The app is the most widely used UK government-related app and operates under the NHS login security framework. Authentication uses NHS login with identity verification through GOV.UK Verify-style processes.

Electronic Prescription Service routes more than ninety percent of UK prescriptions electronically from prescriber to pharmacy. Patients nominate a pharmacy through the app or the surgery; subsequent prescriptions flow there automatically. The Summary Care Record provides allergies and current medications to clinicians outside the patient's regular practice; the Shared Care Record being rolled out provides the full record across health and social care.

Specialist digital services include the e-Referral Service (specialist appointment booking), the National Care Records Service, the National Cancer Records and the National Diabetes Audit. Behind these patient-facing services sits a complex landscape of clinical systems (SystmOne, EMIS Web in primary care; Cerner, Epic and others in secondary care) that have variable interoperability. NHS England's strategy aims to improve cross-system data flow through APIs and shared standards.

Artificial intelligence and machine learning are being deployed cautiously in NHS settings, primarily in imaging diagnostics (radiology AI for cancer detection), pathology (histology AI), and predictive analytics for service planning. Specific NHS Long Term Plan commitments cover AI adoption with safety and equity safeguards. The MHRA regulates AI as a medical device where it provides clinical decision support.

Disclaimer

This article provides general information for UK residents and newcomers. It is not legal, tax, financial or medical advice. Rules, rates, eligibility criteria and processes change frequently; readers should verify details with the linked primary sources or consult an authorised professional before acting on anything described here. References to specific firms, products or services are illustrative and do not constitute endorsements.

Frequently asked questions

What if I have not been invited but I think I should have been?

Contact the local screening centre or the breast screening administration. The most common reasons for missed invitations are recent GP registration, recent move, or being just below the eligible age. The screening centre can confirm the next planned invitation and arrange an earlier appointment if appropriate.

Can I get screening before age fifty?

Routine screening starts at fifty. Women under fifty are not part of the standard programme but may be referred by the GP for symptoms (a lump, change in nipple, persistent skin change). Women at higher risk (strong family history, BRCA mutation) follow an enhanced surveillance pathway that may start earlier; the GP refers based on the risk factors.

Can I have screening over age seventy-one?

Yes, by self-referral every three years. Contact the local screening centre. The benefits of screening continue at older ages but absolute risks of breast cancer in the next three years are part of the individual decision; the screening centre provides information.

Is the screening confidential?

Yes. NHS confidentiality applies to all screening data. Results are shared between the screening service, the GP and (where appropriate) the breast clinic. The patient's wider records are not affected by routine screening except to record the test and result.

Are there alternatives to mammography?

MRI screening is offered for very high-risk women (BRCA carriers, very strong family history) alongside or instead of mammography. Ultrasound is sometimes used in dense breasts. Tomosynthesis (3D mammography) is becoming standard in some centres. The choice depends on the woman's specific risk profile and is decided by the specialist team.